ASPI Boss Speaks Out Amid Acquisition Rumours
Property issuer PT Andalan Sakti Primaindo Tbk (ASPI) has addressed the planned share acquisition by PT GMP Group Investama. The company stressed that the transaction process is still in its early stages and that, to date, no binding agreement exists between the prospective seller and buyer.
Previously, PT GMP Group Investama planned to acquire 51.18% of ASPI’s shares from the controlling shareholder, PT Andalan Sakti Inti (ASI). The number of shares to be transferred amounts to 349,995,000 shares, representing ASI’s entire holding in ASPI.
In its explanation to the Indonesia Stock Exchange (BEI), ASPI’s management conveyed that ASI’s planned share divestment is part of its investment strategy. Meanwhile, GMP’s objective in taking over ASPI’s shares is understood to be part of an investment strategy as well as business development and corporate expansion.
The company also explained that there has been no prior strategic engagement or business cooperation between ASI and GMP. To the company’s knowledge, the meeting between the two parties occurred in connection with GMP’s plan to expand its business activities.
‘Currently, PT GMP is preparing the due diligence stages. The company is still awaiting further confirmation regarding the implementation timeline from the prospective buyer,’ as quoted from the BEI information disclosure, Tuesday (28/7/2026).
ASPI also confirmed that, up to the submission of the information disclosure, ASI has not signed a Conditional Shares Purchase Agreement (CSPA) or any equivalent document with GMP. Consequently, there is no agreement yet on the transaction terms, payment mechanism, settlement schedule, or other points commonly regulated in a CSPA.
The company stated that the parties are still in the initial discussion and negotiation phase. Therefore, no binding agreement has been reached regarding the planned share acquisition.
ASPI added that the target date for signing the CSPA also cannot be determined as the due diligence process has not yet commenced. The agreement will only be signed after the due diligence, discussions on commercial and legal aspects, and negotiations of all preliminary requirements are completed.
Regarding the purpose of the acquisition, the company admitted it has not received detailed information from GMP. However, ASPI understands that the transaction is intended to support the prospective buyer’s investment strategy and business development.
As for the implementation stages of the acquisition, ASPI explained that after the due diligence is completed and the results are deemed satisfactory by both parties, the process will proceed with the signing of the CSPA, followed by the Shares Purchase Agreement (SPA), the execution of the share acquisition by GMP, and finally a mandatory tender offer in accordance with the regulations of the Financial Services Authority (OJK).
Meanwhile, the technical mechanism of the share acquisition, including whether the transaction will be carried out in stages or all at once, has also not been determined. The company stated that these details will only be set out in the definitive agreement, which has yet to be signed.
Source: jawawa.id (https://jawawa.id/newsitem/aspi-boss-speaks-out-amid-acquisition-rumours-1785217888)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20260728105505-17-754349/santer-kabar-mau-diakuisisi-bos-emiten-ri-ini-buka-suara), translated from Indonesian